Updates

BIG PHARMA EARNINGS: JOHNSON & JOHNSON AND NOVARTIS

Jul 23, 2024

Big Pharma Giants Top Wall Street Expectations After Hiking Prices on Read More

CSRXP: BIG PHARMA IS AT IT AGAIN, HIKES PRICES ON NEARLY 200 PRESCRIPTION DRUGS AS PART OF MID-YEAR INCREASES

Jul 15, 2024

Brand Name Drug Giants’ Average Price Increases for June-July Outpace Rate Read More

ICYMI: SENATOR CORNYN DELIVERS REMARKS ON U.S. SENATE PASSAGE OF PATENT THICKET CRACKDOWN

Jul 15, 2024

Lawmakers Unanimously Advance Bipartisan Solution to Help Hold Big Pharma Read More

CSRXP APPLAUDS U.S. SENATE PASSAGE OF BIPARTISAN, MARKET-BASED SOLUTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS

Jul 11, 2024

Legislation Would Hold Big Pharma Accountable for Anti-Competitive Tactics Read More

NEW GOODRX REPORT UNDERSCORES NEED FOR CONGRESS TO HOLD BIG PHARMA ACCOUNTABLE

Jul 2, 2024

Latest Data Finds List Prices of Prescription Drug Prices Have Increased Read More

SECOND OPINION: LATEST PHRMA AD CAMPAIGN DEFENDS PATENT ABUSE “STATUS QUO”

Jun 26, 2024

Big Pharma Advertising Blitz Seeks to Protect Anti-Competitive Tactics That Read More

DOSE OF REALITY: FORBES: HOW BIG PHARMA EXPLOITS LOOPHOLES IN THE PATENT SYSTEM

Jun 25, 2024

Avik Roy Highlights How Increased USPTO-FDA Collaboration and Greater Scrutiny Read More

DOSE OF REALITY: FORBES: HOW BIG PHARMA STIFLES COMPETITION WITH PRODUCT SHOPPING

May 23, 2024

Research Column Explores Case Study in Common Patent Abuse Tactic That Read More

DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE BLOCKS COMPETITION IN THE PRESCRIPTION DRUG MARKET, KEEPS DRUG PRICES HIGH

May 21, 2024

Senate Hearing Offers Opportunity to Highlight Market-Based Solutions to Hold Read More